Navigation Links
FluChip technology licensed to combat deadly flu virus
Date:4/28/2009

Boulder, CO, 4-28-09. InDevR, a small biotech company in Boulder, CO, announced today that they have licensed the FluChip technology from the University of Colorado. The FluChip was invented by a joint team of scientists at the University of Colorado and the Centers for Disease Control and Prevention in an NIH sponsored effort led by Professor Kathy Rowlen.

Rowlen, now the CEO of InDevR, said that InDevR has arranged to test genetic material from the recent swine H1N1 virus on the MChip as well as other versions of the FluChip which are under development.

According to Rowlen "Based on work we conducted a couple of years ago, it appears that the M-gene version of the FluChip will be able to distinguish human H1N1 viruses from the new swine H1N1 virus. If that proves to be the case, the FluChip will be a much needed and powerful new tool for surveillance since all of the current influenza diagnostics on the market are unable to subtype this virus."

The most popular diagnostic tests for influenza include rapid immunoassays, which are only able to identify the type (A or B) of influenza virus, and reverse-transcriptase polymerase chain reaction assays, which were designed for human-adapted influenza viruses and are not able to identify the swine H1N1 subtype. State Public Health Laboratories must now send any influenza A viruses that cannot be subtyped using existing diagnostics to the CDC for analysis by genome sequencing or viral isolation.

The CDC must select viruses to analyze since it is not possible to run every sample collected from a large number of Public Health Labs.

The M-gene based FluChip has been demonstrated to delineate human-adapted viruses from non-human viruses, such as the H1N1 virus that caused the 1918 "Spanish Flu". "Since the FluChip assay can be conducted within a single day it could be employed in State Public Health Laboratories to greatly enhance influenza surveillance and our abi
'/>"/>

Contact: Kathy Rowlen
rowlen@indevr.com
303-402-9100
University of Colorado at Boulder
Source:Eurekalert

2

GOOD

Page: 1 2

Related biology news :

1. BIO-key(R) International Showcasing Biometric Identification Technology at 2009 RSA Conference
2. Combating Terrorism with Commercial Technology: 2009 Force Protection Equipment Demonstration
3. Conference tackles technology needed to address climate change
4. Childrens Hospital Oakland is first pediatric hospital to use laboratory-on-a-card technology
5. Olympus advances technology for laparo-endoscopic single-site surgery
6. Ancient diatoms lead to new technology for solar energy
7. Nanofarming technology harvest biofuel oils without harming algae
8. Cellulosic biofuel technology will generate low-cost green fuel, says major study
9. Ben-Gurion University of the Negev researchers develop new reversible, green window technology
10. Salient Stills Notches Significant Advances in Profitability, Diversity of Sales and Customers, and Video Forensics Technology in 2008
11. QSGI Integrates Fujitsu Mag EraSURE Data Degausser into its Suite of Information Technology Security Services

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...n Antarctic snowmelt that occurred during the 2008...rong positive phases for two main climate drivers,...thern Hemisphere Annular Mode), according to Dr. M...pheric Sciences at The City College of New York. ...l faculty at the CUNY Graduate Center, added that ...
(Date:12/2/2009)... who smoke their first cigarette within minutes af... a by-product of nicotine when processed by the bo...e number of cigarettes smoked. , "Since cotin...er, our results suggest that smokers who smoke imm...r lung cancer," said researcher Joshua E. Muscat, ...
(Date:12/2/2009)..., peanut butter, and other foods have done more th...afety. They also are quietly fueling a boom in the...ew food safety regulations. That,s the topic of th...emical & Engineering News , (C&EN) ACS, weekly new...ey and Senior Correspondent Marc Reisch point out ...
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Increased nicotine levels detected in those who light-up earlier 2Is Smoking Tougher on Women 3F 60033 1Is Smoking Tougher on Women 3F 60033 2Is Smoking Tougher on Women 3F 60033 3New Study Confirms VASER Lipo Results Are Superior to Standard Liposuction 5670 1New Study Confirms VASER Lipo Results Are Superior to Standard Liposuction 5670 2Gene Therapy Offers Hope for Severe Hereditary Eye Disease 60029 1Gene Therapy Offers Hope for Severe Hereditary Eye Disease 60029 2
...searchers at Harvard Medical School and Massachuse...at the 13th European Cancer Conference (ECCO) have...ery is possible using nanoparticle-apatamer conjug...mers) are short DNA or RNA fragments that can bind...nity; analogous to monoclonal antibodies. In the f...
... to suppress HIV replication and has dramatically ...d patients. But the existence of viral reservoirs...eated patients. In a new study appearing on Novemb...-Wook Chun and colleagues from the NIH offer new i...ividuals receiving antiviral therapy. , The autho...
...ocally the coolest - pieces of real estate on the ...g a state-of-the-art superconducting magnet for us... DNA, RNA, enzymes and other proteins. , The inst...r magnet was recently completed in a specially bui...n and a half tons, the magnetic resonance (MR) spe...
Other Biology News:Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 2Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 3Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 4Superconducting magnet attracts molecular research 2
(Date:12/3/2009)..., HOPKINTON, Mass., Dec. 3 /PRNewswire-FirstCall/ ... leading provider of tools and services for drug d...ced Living Image 4.0 software for IVIS® in vi...he more than 800 Caliper IVIS systems currently in...0 features advanced spectral unmixing tools to enh...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlink... is available in its catalogue: ,, Carbondioxi... http://www.reportlinker.com/p0164368/Carbondioxi... ,, Incubators are the most critical equipment ...and other applications for providing a controlled ...
(Date:12/2/2009)... , CALGARY, Dec. 2 /PRNewswire-FirstCall/ - On...y") (TSX:ONC; NASDAQ: ONCY ) announced today that ...ffering, the underwriters have exercised in full t...onal 637,500 units. Each unit is comprised of one ...rrant, and was sold at a price of US$3.00 per unit...
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*BIO Pte ...l oral JAK2 inhibitor, SB1518, at The American Soc...ion in New Orleans. ,, Data will be presented o...ation trial of SB1518 detailing its safety, tolera... profile in dose levels ranging from 100 to 600 mg...
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
...al School Researchers Used Thermo Scientific Dharm... for Reproduction of the Virus that ...31 Thermo Fisher,Scientific Inc., the world leade...-interference (RNAi) technology has enabled a grou...on, which identified human proteins,required for g...
... Manufacture ARIUS, Product Candidate Trop-2 Signa... PRINCETON, N.J., Jan. 31 Laureate Pharma, Inc., ...protein production company, today,announced that i...greement,with ARIUS Research, Inc., a biotechnolog...e next wave of antibody therapeutics to treat canc...
...d Balance Sheet and Advancing Products in 2008 - .... Eastern Time -, BRANFORD, Conn., Jan. 31 CuraG... consolidated financial results for the,fourth qua...raGen reported a loss from operations for the four...share, which included restructuring charges,totali...
Other Biology Technology:Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 2Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 3Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 4Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 5Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody 2Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody 3CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 2CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 3CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 4CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 5CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 6CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 7
Mouse Anti-Human Flavocytochrome b Monoclonal Antibody, FITC Conjugated, Clone 7D5 from MBL International
Chaps Cell Extract Buffer (10X) from Cell Signaling Technology
Rabbit Anti-Human Reptin / TIP49B / RUVB2 Polyclonal Antibody, Unconjugated from Abcam
Anti-Human L-Ficolin Monoclonal Antibody, Unconjugated, Clone GN4 from Cell Sciences
Biology Products: